Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
01 Octobre 2019 - 10:33AM
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem
Cells Subsidiaries and activity.
Esperite N.V. (ESP) : Update to the market on its Cord Blood
Stem Cells Subsidiaries and activity.
Amsterdam, The Netherlands – 1st October 2019
Esperite N.V. (the Group) confirmed on 22nd February 2019 the
intentions of the Group to sell its Cord Blood Stem Cells
activities in an transaction composed by two main elements. The
Storage Agreement signed between CryoSave AG and its new Polish
partner, which main advantages is to consolidate all the samples
from different country in one secured location and to secure a long
term contract with a reputable company. The second element, related
to the transfer of the main assets, as brand names, CryoSave and
Salveo mainly, databases, websites and other IT tools, has been
concluded finally on August 20th 2019 with the Myrisoph Capital
Group (Myrisoph).The transportation of the samples from the
different locations was completed and communicated with the press
release issued on July 1st 2019. Anticipating the conclusion of the
agreement formalized with a binding offer by Myrisoph, CryoSave
took the decision to progressively terminate its activities in
Switzerland. The laboratory in Plan-les-Ouates was shut down at the
end of June 2019. After the Cord Blood Stem Cells samples have been
safely transferred and the activity licenced to Myrisoph Capital,
Esperite had no other choice than to accept the liquidation of its
entities related to Stem Cell, CryoSave AG which deadline to oppose
was on 26th September 2019. The Group will soon update the market
on the impact on the consolidated revenues.Esperite has the
intention take distance from the operative part of its activities
and focus its effort on turning itself in an investment company
with a focus on Health Care and High Tech Service.
ESPERITE group, listed at Euronext Amsterdam and Paris. To learn
more about the ESPERITE Group, or to book an interview:
info@esperitegroup.com or visit the websites at
www.esperite.com.
- Esperite N.V. (ESP) Update to the market on its Cord Blood Stem
Cells Subsidiaries and activity.